By Amy Banks
We’re excited to share the successful installation of Horizon 3.0 at Bowmere Hospital, Countess of Chester Health Park, UK, part of the Cheshire and Wirral Partnership NHS Foundation Trust. A big thank you to Jamie Robertson and Derin Rose for their excellent work on the installation, and to David Wilkinson for ensuring everything went smoothly … Continued
By Amy Banks
Magstim EGI, HD-EEG Appears in National Geographic: Advancing Brain Research on a Global Stage We are thrilled to announce that Magstim EGI, HD-EEG has been featured again in National Geographic’s special issue, Your Brain: 100 Things You Never Knew. This recognition highlights the innovative technology behind Magstim EGI’s EEG solutions and their role in advancing … Continued
By Amy Banks
Transcranial Magnetic Stimulation (TMS) has emerged as a transformative tool in both clinical and research settings, offering non-invasive brain stimulation to treat various neurological and psychiatric disorders. Among the pioneers in this field is Magstim, with a rich history spanning four decades, Magstim has been at the forefront of innovation in neurotechnology. A recent study … Continued
By Amy Banks
Breaking New Ground: Magstim 2002 TMS Stimulator Cited in Science Robotics In the latest edition of Science Robotics (January 2025), an exciting study has taken center stage, exploring the boundaries of motor expertise and innovation in sensory integration. The study, “Surmounting the Ceiling Effect of Motor Expertise by Novel Sensory Experience with a Hand Exoskeleton”, … Continued
By Amy Banks
Magstim is excited to announce our participation in this year’s BrainStim conference, taking place in the vibrant and dynamic setting of Japan. As a global leader in transcranial magnetic stimulation (TMS) and neurotechnology solutions, we’re thrilled to connect with the brightest minds in neuroscience and mental health research. Visit Us at Booth 17-18 Find us … Continued
By Amy Banks
Last month, Magstim attended the Royal College of Psychiatrists conference, where Neuromodulation Techniques, particularly Transcranial Magnetic Stimulation (TMS), took center stage. A key highlight was Professor Richard Morris’ presentation on the BRIGhTMIND study, which demonstrated the effectiveness of TMS as a first-line treatment over Electroconvulsive Therapy (ECT). With positive results and a milder side effect … Continued
By Amy Banks
Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved By UKCA For NHS & Private UK Clinics UK System for Patient Treatment of MDD, OCD and Decreasing Anxiety* Carmarthenshire, UK — (December 5, 2024) – Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded UKCA clearance for the Horizon Inspire … Continued
By Amy Banks
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression* Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective Treatment MINNEAPOLIS, Minn. & Carmarthenshire, UK — (November 12, 2024) – Magstim, the global leader in neuroscience research and treatment for mental health, has been … Continued
By Amy Banks
Karen Wendt, Magstim EGI European Sales Manager attended the Society for Psychophysiological Research (SPR) Conference in Prague last week. The event kicked off with a Welcome Reception on Wednesday evening, where attendees had an introduction to the first Poster Session. The following days were filled with symposia, posters, and plenaries covering a broad range of … Continued
By Amy Banks
We are excited to announce that Magstim attended the Society for Neuroscience (SFN) 2024 conference! SFN is the premier event for neuroscience professionals, and this year we had the opportunity to showcase our latest innovations to study and treat the brain with non-invasive neuromodulation. We demonstrated our advanced transcranial magnetic stimulation (TMS) systems, which … Continued